On October 2, Oracle rose 3.38% in regular trading, trading at $143.27/share, with turnover of $523 million. The gain extends a broader recovery from the sharp sell-off triggered by the company's force majeure notice on its New Mexico data center project in late September.

On the news front, an SEC filing revealed that Oracle director Stephen H. Rusckowski purchased approximately 25,000 shares on September 29 for $3.4838 million, bringing his total holdings to 25,450 shares of common stock. Insider buying at this scale often signals management confidence in the company's valuation following recent weakness.

The rebound also builds on positive product momentum. Oracle recently launched Fusion Claw, an AI execution runtime alongside 25 new AI applications, and introduced two agentic AI investigation tools targeting financial crime and anti-money laundering compliance. These AI agents autonomously conduct preliminary investigations on suspicious activity, filtering false positives and significantly streamlining compliance workflows.

Options market activity has tilted notably bullish in recent sessions, highlighted by a $9.52 million cross-calendar call spread and a $2.04 million sale of deep out-of-the-money puts, reflecting institutional conviction in sustained upside. The call/put volume ratio reached 2.14, underscoring broad directional optimism.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)